DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma

Clinical Radiology

Volumn 69, Issue 6, 2014, Pages

  Shin, K E ^a   Ahn, K J ^b   Choi, H S ^b   Jung, S L ^b   Kim, B S ^b   Jeon, S S ^b   Hong, Y G ^b  

^a Kyung Hee University College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBUTROL; TEMOZOLOMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASTROCYTOMA; BRAIN BLOOD VOLUME; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHANCED NUCLEAR MAGNETIC RESONANCE IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; ADJUVANT CHEMORADIOTHERAPY; ANAPLASTIC OLIGOASTROCYTOMA; CANCER GRADING; COMPARATIVE STUDY; CONTROLLED STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE PERFUSION IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE PERFUSION IMAGING; ECHO PLANAR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; LOW GRADE ASTROCYTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION DOSE; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; CONTRAST MEDIA; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84899906719     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2014.01.016     Document Type: Article

References (36)

1. M.D. Walker, E. Alexander Jr., and W.E. Hunt et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J Neurosurg 49 1978 333 343
2. R. Stupp, W.P. Mason, and M.J. van den Bent et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
3. G.M. Fatterpekar, D. Galheigo, and A. Narayana et al. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum - use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI AJR Am J Roentgenol 198 2012 19 26
4. D. Brandsma, L. Stalpers, and W. Taal et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas Lancet Oncol 9 2008 453 461
5. E.R. Gerstner, M.B. McNamara, and A.D. Norden et al. Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression J Neurooncol 94 2009 97 101
6. M.C. de Wit, H.G. de Bruin, and W. Eijkenboom et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression Neurology 63 2004 535 537
7. R. Mangla, G. Singh, and D. Ziegelitz et al. Changes in relative cerebral blood volume 1 month after radiation - temozolomide therapy can help predict overall survival in patients with glioblastoma Radiology 256 2010 575 584
8. T. Sugahara, Y. Korogi, and S. Tomiguchi et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue AJNR Am J Neuroradiol 21 2000 901 909
9. L.S. Hu, L.C. Baxter, and K.A. Smith et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements AJNR Am J Neuroradiol 30 2009 552 558
10. J. Narang, R. Jain, and A.S. Arbab et al. Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion Neuro Oncol 13 2011 1037 1046
11. Y.H. Kim, S.W. Oh, and Y.J. Lim et al. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI Clin Neurol Neurosurg 112 2010 758 765
12. K. Lutz, A. Radbruch, and B. Wiestler et al. Neuroradiological response criteria for high-grade gliomas Clin Neuroradiol 21 2011 199 205
13. C. Hlaihel, L. Guilloton, and J. Guyotat et al. Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas J Neurooncol 97 2010 73 80
14. B.M. McCormack, D.C. Miller, and G.N. Budzilovich et al. Treatment and survival of low-grade astrocytoma in adults - 1977-1988 Neurosurgery 31 1992 636 642 discussion 42
15. A. Jahangiri, and M.K. Aghi Pseudoprogression and treatment effect Neurosurg Clin N Am 23 2012 277 287 viii-ix
16. J. Voglein, J. Tuttenberg, and M. Weimer et al. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spectroscopic MRI techniques for identifying treatment failure Invest Radiol 46 2011 390 400
17. P.S. Tofts, and A.G. Kermode Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts Magn Reson Med 17 1991 357 367
18. P.S. Tofts, G. Brix, and D.L. Buckley et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232
19. M.R. Orton, J.A. d'Arcy, and S. Walker-Samuel et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI Phys Med Biol 53 2008 1225 1239
20. J.H. Kim, J.M. Lee, and J.H. Park et al. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment - a preliminary study Radiology 266 2013 185 196
21. O. Wu, L. Ostergaard, and R.M. Weisskoff et al. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix Magn Reson Med 50 2003 164 174
22. J.L. Clarke, and S. Chang Pseudoprogression and pseudoresponse: challenges in brain tumor imaging Curr Neurol Neurosci Rep 9 2009 241 246
23. S. Cha, J.M. Lupo, and M.H. Chen et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging AJNR Am J Neuroradiol 28 2007 1078 1084
24. R.F. Barajas Jr., J.S. Chang, and M.R. Segal et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging Radiology 253 2009 486 496
25. I. Caroline, and M.A. Rosenthal Imaging modalities in high-grade gliomas: pseudoprogression, recurrence, or necrosis? J Clin Neurosci 19 2012 633 637
26. S. Cha, E.A. Knopp, and G. Johnson et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging Radiology 223 2002 11 29
27. M. Essig, M.S. Shiroishi, and T.B. Nguyen et al. Perfusion MRI: the five most frequently asked technical questions AJR Am J Roentgenol 200 2013 24 34
28. A.R. Padhani, and J.E. Husband Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation, and human studies Clin Radiol 56 2001 607 620
29. Y. Cao, P.C. Sundgren, and C.I. Tsien et al. Physiologic and metabolic magnetic resonance imaging in gliomas J Clin Oncol 24 2006 1228 1235
30. S. Bisdas, T. Naegele, and R. Ritz et al. Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging Acad Radiol 18 2011 575 583
31. B. Huang, C.S. Wong, and B. Whitcher et al. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage Eur Radiol 23 2013 1495 1502
32. P.C. Burger, M.S. Mahley Jr., and L. Dudka et al. The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases Cancer 44 1979 1256 1272
33. C. Tsien, C.J. Galban, and T.L. Chenevert et al. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma J Clin Oncol 28 2010 2293 2299
34. D.S. Kong, S.T. Kim, and E.H. Kim et al. Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status AJNR Am J Neuroradiol 32 2011 382 387
35. D.K. Tran, and R.L. Jensen Treatment-related brain tumor imaging changes: so-called "pseudoprogression" vs. tumor progression: review and future research opportunities Surg Neurol Int 4 2013 S129 S135
36. E. Van Mieghem, A. Wozniak, and Y. Geussens et al. Defining pseudoprogression in glioblastoma multiforme Eur J Neurol 20 2013 1335 1341